Has TB-500 been tested in humans?
No. The FDA's 2026 review found no published study giving TB-500 to a person in any form, and no side-effect reports for it in the FDA's safety database. The first registered study of the piece in people only began signing people up in February 2026. It is a small early study in 80 people with stable hardening of the arteries. Every claim about TB-500's effects in people is currently borrowed from a different molecule, the full-length parent peptide. Profile at /compounds/tb-500.
Studies in people from the compound pages this answer belongs to
Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.
Part of healing and recovery peptides. BPC-157, TB-500, GHK-Cu, and the tissue repair family, including what actually has human data.